Can a patient with depression and Attention Deficit Hyperactivity Disorder (ADHD) start Zoloft (sertraline) 50mg and Wellbutrin (bupropion) 150mg simultaneously for depression and ADHD symptoms?

Starting Zoloft and Wellbutrin Simultaneously for Depression and ADHD

Yes, you can start both Zoloft 50mg and Wellbutrin 150mg simultaneously for a patient with depression and ADHD symptoms, though this approach has important limitations you need to understand. 1

Critical Context: This Is Not Optimal First-Line Treatment

The combination of two antidepressants as initial therapy has limited evidence in children and adolescents and should not be your default approach. 1 The American Academy of Child and Adolescent Psychiatry explicitly states there is "limited evidence for the use of two antidepressants as an initial treatment approach." 1

More importantly: Wellbutrin is a second-line agent for ADHD, not first-line. 2 Stimulants (methylphenidate or amphetamines) achieve 70-80% response rates for ADHD with the strongest evidence base from over 161 randomized controlled trials. 2, 3 Bupropion has more modest effects and should only be considered when stimulants are contraindicated, not tolerated, or when active substance use disorder is present. 2, 3

The Better Algorithm: Sequential Treatment Based on Severity

If Depression is Severe (Primary Problem)

• Start with Zoloft alone at 25-50mg daily, titrating based on response. 2
• SSRIs remain the treatment of choice for depression and are weight-neutral with long-term use. 2
• Reassess ADHD symptoms after 4-6 weeks of adequate antidepressant treatment. 2
• If ADHD symptoms persist despite improved mood, add a stimulant (not bupropion) to the SSRI regimen. 2
• This combination (SSRI + stimulant) has been specifically studied and shown to be safe and effective, with no significant drug-drug interactions. 2, 4

If ADHD is Moderate-to-Severe (Primary Problem)

• Start with a stimulant first, even when depression is present. 2
• Stimulants work rapidly (within days), allowing quick assessment of ADHD response. 2
• Treatment of ADHD alone may resolve comorbid depressive symptoms in many cases without additional medication. 2
• A nationwide longitudinal cohort study of 38,752 individuals found that ADHD medication was associated with a 58% reduced long-term risk for depression (hazard ratio 0.58,95% CI 0.51-0.67). 5
• If depressive symptoms persist after 4-6 weeks of optimized stimulant therapy, then add Zoloft to the regimen. 2

When the Dual Antidepressant Approach Might Be Justified

You can proceed with starting both medications simultaneously if:

• The patient has active substance use disorder (bupropion is uncontrolled with no abuse potential). 3
• The patient has failed or cannot tolerate stimulants after adequate trials. 2, 3
• There are concerns about stimulant misuse or diversion. 3
• The patient has uncontrolled hypertension (bupropion has less pronounced cardiovascular effects than stimulants). 3
• The patient needs smoking cessation support (bupropion is FDA-approved for this). 3

Evidence Supporting Combination Antidepressant Therapy

A double-blind randomized study found that combination antidepressant therapy from treatment initiation doubled remission rates compared to monotherapy (52-58% vs 25% for fluoxetine alone). 6 However, this study used mirtazapine combinations, not specifically sertraline plus bupropion.

For adolescents specifically, an open-label study of bupropion SR in 24 adolescents with comorbid ADHD and depression found that 58% were responders in both conditions, with significant improvements in both depressive and ADHD symptomatology. 7 However, this was not a placebo-controlled trial.

Critical Safety Considerations

Before prescribing bupropion, screen for absolute contraindications: 3

• Current or prior seizure disorder
• Eating disorders (anorexia or bulimia)
• Abrupt discontinuation of alcohol, benzodiazepines, or antiepileptic drugs
• Concurrent MAO inhibitor use or within 14 days of discontinuation

Monitor for common side effects: 3

• Headache, insomnia, anxiety (bupropion's activating properties may worsen hyperactivity)
• Dry mouth, nausea, constipation
• Black box warning: suicidal thoughts in young adults during first few months

No significant pharmacokinetic interactions exist between bupropion and SSRIs. 3

Monitoring Plan Required

Before starting combination therapy, you must develop a treatment and monitoring plan, educate the patient and family, and obtain informed consent. 1 This includes:

• Baseline assessment: Blood pressure, pulse, seizure risk factors, eating disorders, substance use, suicidality. 3
• Weekly contact during titration, then monthly during maintenance. 3
• Systematic assessment of both ADHD and depressive symptoms using standardized rating scales.
• Monitor for suicidality, particularly in the first few months. 3

Common Pitfalls to Avoid

Do not assume a single antidepressant will effectively treat both ADHD and depression. 2 The evidence explicitly states no single antidepressant is proven for this dual purpose, and SSRIs provide no observable improvement in ADHD symptoms. 4

Do not use bupropion alone to treat both conditions as first-line therapy. 2 Bupropion is a second-line agent for ADHD compared to stimulants. 2

Do not mistake behavioral reactions to psychosocial stressors as symptoms requiring medication adjustments. 1 The prescriber who doesn't appreciate the need for combined psychosocial and pharmacological treatment may unnecessarily expose the patient to increasingly complex medication strategies. 1